BioSign Technologies
 |
Richard Potts, Chairman & CEO
Biosign Technologies Inc.
P 416.218.9800 ext. 234
E richardp@biosign.com
W www.biosign.com
Biosign Technologies Inc. is a medical technology company offering standards-based solutions to critical healthcare problems. Biosign’s core technology is a compact, easy-to-use web-based instrument that enables examination of vital signs beyond the confines of traditional healthcare settings. The instrument will uniquely integrate hardware and software technologies into an expert system that provides multiple clinical tests from a single reading of the arterial pulse. This digital information can be securely stored in an electronic health record and used to aid in diagnostics and disease management. The signal database can also be used in drug research and clinical trials, best practice studies, validating health policy, and more.
The company’s solutions are focused on maximizing healthcare resources by: enforcing compliance with best practices; sustaining an extensive, effective and flexible care environment; and enabling patient participation in decision making. Biosign is set to propose its technology as a standard for testing, monitoring and measuring health outcomes in chronic diseases such as hypertension and diabetes.
BROWSE PAGES
- Ambit Biosciences
- AXS Biomedical Animation Studio
- BioSign Technologies
- Constab Pharmaceutical Inc.
- Clera Inc.
- Diagnostic Systems Laboratories
- Interface Biologics Inc.
- Invisage Technologies Inc.
- In Vitro Drug Safety and Biotechnology
- Kanata Chemical Technologies
- Larial Proteomics Inc.
- Matregen
- OCBN
- Octopz
- Pro Lab Developments
- Receptor Therapeutics Inc.
- Skymeter Corporation
- Space Quest
- YYZ Blue Sky Capital Corporation
